Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1321-1330 of 1,873) with videos related to

Pageof 188
Sort By:
JAMA Cardiology|October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVERAkshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.
European Journal of Heart Failure|July 26, 2024
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MIFinnian R Mc Causland, Martina M McGrath, Brian L Claggett, et al.
Journal of Cardiac Failure|May 27, 2024
Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF TrialMarat Fudim, Derek D Cyr, Jonathan H Ward, et al.
European Journal of Heart Failure|July 4, 2023
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fractionMingming Yang, Toru Kondo, Carly Adamson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 8, 2021
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERELi Shen, Brian L Claggett, Pardeep S Jhund, et al.
European Journal of Heart Failure|September 8, 2025
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trialJohn W Ostrominski, Brian L Claggett, Akshay S Desai, et al.
Journal of the American College of Cardiology|March 18, 2026
Comparative Prognosis of Chagas and Other CardiomyopathiesRyohei Ono, Kieran F Docherty, Alasdair D Henderson, et al.
Microbiome|May 9, 2024
Gut microbiota, blood metabolites, and left ventricular diastolic dysfunction in US Hispanics/LatinosKai Luo, Alkis Taryn, Eun-Hye Moon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
European Heart Journal|August 29, 2025
Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failureKieran F Docherty, Benjamin Heywood, Antoni Bayes-Genis, et al.
Pageof 188

Showing results (1321-1330 of 1,873) with videos related to

Sort By:
Pageof 188
JAMA Cardiology|October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVERAkshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.
European Journal of Heart Failure|July 26, 2024
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MIFinnian R Mc Causland, Martina M McGrath, Brian L Claggett, et al.
Journal of Cardiac Failure|May 27, 2024
Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF TrialMarat Fudim, Derek D Cyr, Jonathan H Ward, et al.
European Journal of Heart Failure|July 4, 2023
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fractionMingming Yang, Toru Kondo, Carly Adamson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 8, 2021
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERELi Shen, Brian L Claggett, Pardeep S Jhund, et al.
European Journal of Heart Failure|September 8, 2025
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trialJohn W Ostrominski, Brian L Claggett, Akshay S Desai, et al.
Journal of the American College of Cardiology|March 18, 2026
Comparative Prognosis of Chagas and Other CardiomyopathiesRyohei Ono, Kieran F Docherty, Alasdair D Henderson, et al.
Microbiome|May 9, 2024
Gut microbiota, blood metabolites, and left ventricular diastolic dysfunction in US Hispanics/LatinosKai Luo, Alkis Taryn, Eun-Hye Moon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
European Heart Journal|August 29, 2025
Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failureKieran F Docherty, Benjamin Heywood, Antoni Bayes-Genis, et al.
Pageof 188